Seasonality of Rotavirus Infection with its Vaccination
نویسندگان
چکیده
The impact of rotavirus, the most prevalent diarrheal pathogen in young children worldwide, may be reduced by either a recently approved vaccine or others in development. The dynamics of rotavirus infections are studied using a simple mathematical model that includes the impact of breast feeding, seasonality and the possibility of control via vaccination. Data from Australia are fitted to a model that incorporates the effect of seasonality in the transmission process. The impact of temporary and partially effective vaccines is explored. Finally, the issue of cost is briefly discussed in the context of identifying “optimal” vaccination strategies. 1. On the characteristics of rotavirus Rotavirus spreads easily especially among infants. In fact, 95% of children worldwide are infected by the time they reach age 5 with peak incidence occurring between ages 4 months and 36 months [20]. CDC epidemiologist Umesh Parashar reported at an international meeting on the epidemiology of the rotavirus held in Mexico City (2004) that rotavirus was detected in 60% of stool samples from children hospitalized with severe diarrhea in Vietnam; 41 % in China; 56% in Myanmar; and 29% in Hong Kong [23]. In the United States, approximately 2.7 million children under 5 years of age are infected by rotavirus each year, resulting in 500,000 visits to physicians and 50,000 hospitalizations per year. The estimated direct cost of medical care is about $274 million with $1 billion per year in associated costs in the U.S. alone [21],[28]. In Peru, for example, the total medical care costs directly linked to rotavirus infections are estimated to be around $2.6 million (U.S.) a year [38], an amount that includes the costs associated with 64,000 clinic visits and 30,000 hospitalizations per year. A study presented at the European Society for the Study and Prevention of Infant Death (ESPID) quantified the burden associated with rotavirus disease in the new European Union (EU). Their estimates used a model recently developed by the U.S. Centers for Disease Control and Prevention (CDC). The EU managed to obtain country specific estimates of rotavirus levels of infections in each of its 25 member states [33]. These estimates revealed nearly 4.5 million episodes of rotaviral disease among the 24 million children under 5 years [33]. In other words, about one out of every five children has experienced a rotavirus infection before age 5 within the EU. 1991 Mathematics Subject Classification. Primary 92D30; Secondary 62F25.
منابع مشابه
Sustained Decrease in Laboratory Detection of Rotavirus after Implementation of Routine Vaccination — United States, 2000–2014
Rotavirus infection is the leading cause of severe gastroenteritis among infants and young children worldwide. Before the introduction of rotavirus vaccine in the United States in 2006, rotavirus infection caused significant morbidity among U.S. children, with an estimated 55,000-70,000 hospitalizations and 410,000 clinic visits annually. The disease showed a characteristic winter-spring season...
متن کاملSubunit Vaccine Preparation of Bovine Rotavirus and Its Efficacy in Mice
Background: Rotaviruses (RV) are important viral diarrheal agents in calves. Vaccination is an optimum measure to prevent bovine rotaviruses (BRV) infection. However, little research on BRV VP7 vaccine has been done and currently there is no BRV vaccine. Objective: To prepare a subunit vaccine of BRV and investigate its efficacy. Methods: Total RNA was extracted from MA104 cells infected with b...
متن کاملCost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France.
BACKGROUND It is estimated that annually 300 000 cases of rotavirus-induced gastroenteritis (RVGE) occur in children aged up to 5 years in France. A two-dose vaccine against rotavirus infection (RIX4414; Rotarix, GlaxoSmithKline), has been shown to be highly effective against severe RVGE. OBJECTIVE This study evaluated the cost effectiveness of general vaccination against rotavirus using RIX4...
متن کاملAssessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs.
Two new vaccines against severe rotavirus gastroenteritis that have high efficacy in middle- and high-income countries have recently been licensed in many countries worldwide. Clinical trials in low-income countries in Africa and Asia are ongoing. Experience gained through studies of natural rotavirus infection and the clinical trials for the current and previous rotavirus vaccines indicate tha...
متن کاملRota Viral Infection: A Significant Disease Burden to Libya
BACKGROUND Rotavirus is a common infection causing 450,000 deaths annually primarily in children 5 years and below. Despite the high burden of disease, little is known about the epidemiology of rotavirus in Libya. The aim of this study was to estimate the rotavirus disease burden among Libyan children. METHODS A cross-sectional study was carried out prospectively among children 5 years old an...
متن کامل